D-ribose, a metabolic substrate for congestive heart failure.
The incidence of congestive heart failure continues to escalate worldwide, taxing health care systems. Current therapies focus on clinical management. Current accepted regimens have provided some success; however, most patients show progression of their disease. Because of this failure, research continues to explore therapies directed at stabilization of their disease and hopefully to improve the downward spiral. Publications have asserted that the failing heart is energy starved. D-ribose, a naturally occurring pentose carbohydrate and a key component in the adenosine triphosphate (ATP) molecule, has demonstrated an ability to replenish ATP levels and improve diastolic dysfunction following myocardial ischemia, which has been shown to improve the clinical state of patients afflicted with congestive heart failure. D-ribose may provide the necessary metabolic substrate to benefit this energy-deficient state found in heart failure.
Wagner
Susan
S
Saddleback Memorial Hospital, Laguna, CA, USA.
Herrick
James
J
Shecterle
Linda M
LM
St Cyr
John A
JA
D000255:Adenosine Triphosphate / Q000096:biosynthesis; D019587:Dietary Supplements; D006333:Heart Failure / Q000628:therapy*; D006801:Humans; D012266:Ribose / Q000627:therapeutic use*
D012266:Ribose; D000255:Adenosine Triphosphate